{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T05:11:02Z","timestamp":1739682662094,"version":"3.37.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Diagnostic Radiology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1067\/j.cpradiol.2024.08.009","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T09:33:59Z","timestamp":1723541639000},"page":"251-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The tipping point: Key oncologic imaging findings resulting in critical changes in the management of malignant genitourinary and gynecological tumors"],"prefix":"10.1067","volume":"54","author":[{"given":"Mohammad Reza","family":"Rouhezamin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna I.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh","family":"Harisinghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul N.","family":"Uppot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/j.cpradiol.2024.08.009_bib0001","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ucl.2020.04.002","article-title":"Epidemiology, risk assessment, and biomarkers for patients with advanced renal cell carcinoma","volume":"47","author":"Attalla","year":"2020","journal-title":"Urol Clin North Am"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0002","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0003","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s00261-016-0940-3","article-title":"A practical imaging classification for the non-invasive differentiation of renal cell carcinoma into its main subtypes","volume":"42","author":"Cupido","year":"2017","journal-title":"Abdom Radiol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0004","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1007\/s00261-016-1029-8","article-title":"Abdominal seeding of renal cell carcinoma: radiologic, pathologic, and prognostic features","volume":"42","author":"Park","year":"2017","journal-title":"Abdom Radiol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0005","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jacr.2016.01.021","article-title":"ACR appropriateness criteria renal cell carcinoma staging","volume":"13","author":"Vikram","year":"2016","journal-title":"J Am Coll Radiol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0006","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1200\/JCO.1998.16.6.2261","article-title":"Resection of metastatic renal cell carcinoma","volume":"16","author":"Kavolius","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0007","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.urolonc.2020.02.003","article-title":"Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era","volume":"38","author":"Takagi","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0008","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2214\/AJR.21.25493","article-title":"Update on the role of imaging in clinical staging and restaging of renal cell carcinoma based on the AJCC 8th edition, from the AJR special series on cancer staging","volume":"217","author":"Elkassem","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0009","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2214\/ajr.148.1.59","article-title":"Renal adenocarcinoma: CT staging of 100 tumors","volume":"148","author":"Johnson","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0010","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/jmri.1880030408","article-title":"Renal cancer staging: Comparison of contrast-enhanced CT and gadolinium-enhanced fat-suppressed spin-echo and gradient-echo MR imaging","volume":"3","author":"Semelka","year":"1993","journal-title":"J Magn Reson Imaging"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0011","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/S0022-5347(05)65519-X","article-title":"The diagnostic value of bone scan in patients with renal cell carcinoma","volume":"166","author":"Koga","year":"2001","journal-title":"J Urol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0012","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.eururo.2007.08.053","article-title":"High frequency of intracerebral hemorrhage in metastatic renal carcinoma patients with brain metastases treated with tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptor","volume":"53","author":"Pouessel","year":"2008","journal-title":"Eur Urol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0013","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0140-6736(98)01041-1","article-title":"Kidney cancer","volume":"352","author":"Vogelzang","year":"1998","journal-title":"Lancet"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0014","doi-asserted-by":"crossref","DOI":"10.1007\/s11934-018-0829-5","article-title":"Imaging for screening and surveillance of patients with hereditary forms of renal cell carcinoma","volume":"19","author":"Freifeld","year":"2018","journal-title":"Curr Urol Rep"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0015","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0022-5347(01)62509-6","article-title":"Prevalence, morphology and biology of renal cell carcinoma in Von Hippel-Lindau disease compared to sporadic renal cell carcinoma","volume":"160","author":"Neumann","year":"1998","journal-title":"J Urol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0016","series-title":"Neurocutaneous Syndromes","first-page":"139","article-title":"Hippel\u2013Lindau disease","author":"Chittiboina","year":"2015"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0017","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.rcl.2017.06.007","article-title":"& Pedrosa, I. Imaging and screening of kidney cancer","volume":"55","author":"Diaz de Leon","year":"2017","journal-title":"Radiol Clin North Am"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0018","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1158\/1078-0432.CCR-22-1054","article-title":"FDA approval summary: Belzutifan for von Hippel-Lindau disease\u2013associated tumors","volume":"28","author":"Fallah","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0019","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0022-5347(05)68930-6","article-title":"Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery","volume":"161","author":"Walther","year":"1999","journal-title":"J Urol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0020","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10689-014-9735-2","article-title":"Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment","volume":"13","author":"Menko","year":"2014","journal-title":"Fam Cancer"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0021","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10689-013-9657-4","article-title":"Diagnosis and management of BHD-associated kidney cancer","volume":"12","author":"Stamatakis","year":"2013","journal-title":"Fam Cancer"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0022","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3389\/fphys.2017.00947","article-title":"Identification of biomarkers correlated with the TNM staging and overall survival of patients with bladder cancer","volume":"8","author":"Li","year":"2017","journal-title":"Front Physiol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0023","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0024","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/RCT.0000000000001322","article-title":"Radiologic diagnosis and staging of bladder cancer: an update","volume":"46","author":"Awiwi","year":"2022","journal-title":"J Comput Assist Tomogr"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0025","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2214\/AJR.20.22763","article-title":"Overview of VI-RADS in bladder cancer","volume":"214","author":"Pecoraro","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0026","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.urolonc.2015.08.018","article-title":"Contemporary role of advanced imaging for bladder cancer staging","volume":"34","author":"Rais-Bahrami","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0027","doi-asserted-by":"crossref","first-page":"866","DOI":"10.6004\/jnccn.2022.0041","article-title":"NCCN guidelines\u00ae insights: Bladder Cancer, version 2.2022","volume":"20","author":"Flaig","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0028","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0029","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2017.09.030","article-title":"The role of surgery in metastatic bladder cancer: a systematic review","volume":"73","author":"Abufaraj","year":"2018","journal-title":"Eur Urol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1148\/radiol.2511080873","article-title":"Urinary bladder cancer: Diffusion-weighted MR imaging\u2014accuracy for diagnosing T stage and estimating histologic grade","volume":"251","author":"Takeuchi","year":"2009","journal-title":"Radiology"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0031","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s00330-010-1998-x","article-title":"Staging of uterine cervical cancer with MRI: guidelines of the European society of urogenital radiology","volume":"21","author":"Balleyguier","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0032","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2967\/jnumed.114.145011","article-title":"Evaluation of gynecologic cancer with MR imaging, 18F-FDG PET\/CT, and PET\/MR imaging","volume":"56","author":"Lee","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0033","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1148\/rg.326125519","article-title":"The revised FIGO staging system for uterine malignancies: implications for MR imaging","volume":"32","author":"Freeman","year":"2012","journal-title":"Radiographics"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0034","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1148\/radiol.2017170963","article-title":"Identification of distant metastatic disease in uterine cervical and endometrial cancers with FDG PET\/CT: Analysis from the ACRIN 6671\/GOG 0233 multicenter trial","volume":"287","author":"Gee","year":"2018","journal-title":"Radiology"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0036","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijgo.13865","article-title":"Cancer of the cervix uteri: 2021 update","volume":"155","author":"Bhatla","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0037","doi-asserted-by":"crossref","first-page":"64","DOI":"10.6004\/jnccn.2019.0001","article-title":"Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Koh","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0038","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.soncn.2019.02.003","article-title":"Cervical cancer: An overview of pathophysiology and management","volume":"35","author":"Johnson","year":"2019","journal-title":"Semin Oncol Nurs"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2022.200238","article-title":"Cervical cancer therapies: current challenges and future perspectives","volume":"13","author":"Burmeister","year":"2022","journal-title":"Tumour Virus Res"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0040","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1634\/theoncologist.2002-0342","article-title":"& U.S. Preventative Services Task Force. Guidelines for the treatment of recurrent and metastatic cervical cancer","volume":"7","author":"Friedlander","year":"2002","journal-title":"Oncologist"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0041","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.clon.2016.10.002","article-title":"The impact of systemic therapy beyond first-line treatment for advanced cervical cancer","volume":"29","author":"McLachlan","year":"2017","journal-title":"Clin Oncol R Coll Radiol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0042","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0043","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.radonc.2015.11.013","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"117","author":"Colombo","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0044","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(12)60442-5","article-title":"Contemporary management of endometrial cancer","volume":"379","author":"Wright","year":"2012","journal-title":"Lancet"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0045","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1007\/s00261-021-03220-7","article-title":"Endometrial cancer from early to advanced-stage disease: an update for radiologists","volume":"46","author":"Luna","year":"2021","journal-title":"Abdom Radiol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0046","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejogrb.2017.04.015","article-title":"BGCS uterine cancer guidelines: Recommendations for practice","volume":"213","author":"Sundar","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0047","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1148\/radiol.11110984","article-title":"Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging","volume":"262","author":"Beddy","year":"2012","journal-title":"Radiology"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0048","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.3802\/jgo.2023.34.e85","article-title":"FIGO staging of endometrial cancer: 2023","volume":"34","author":"Berek","year":"2023","journal-title":"J Gynecol Oncol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0049","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2015.62.5459","article-title":"Postoperative radiation therapy for endometrial cancer: American society of clinical oncology clinical practice guideline endorsement of the American society for radiation oncology evidence-based guideline","volume":"33","author":"Meyer","year":"2015","journal-title":"J Clin Oncol"},{"year":"2012","series-title":"Laparoscopy Versus Laparotomy for the Management of Early Stage Endometrial Cancer","author":"Galaal","key":"10.1067\/j.cpradiol.2024.08.009_bib0050"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0051","article-title":"Surgical approach to hysterectomy for benign gynaecological disease","volume":"2015","author":"Aarts","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0052","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/IGC.0000000000000609","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"26","author":"Colombo","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0053","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2214\/AJR.15.15199","article-title":"Ovarian cancer, the revised FIGO staging system, and the role of imaging","volume":"206","author":"Javadi","year":"2016","journal-title":"AJR Am J Roentgenol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0054","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"FIGO guidelines: staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynecol Obstet"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2021 update","volume":"155","author":"Berek","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0056","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ygyno.2015.02.013","article-title":"Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer","volume":"137","author":"Dinkelspiel","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0057","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00280-017-3501-8","article-title":"Advances in ovarian cancer therapy","volume":"81","author":"Cortez","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1067\/j.cpradiol.2024.08.009_bib0058","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210091","article-title":"Ovarian cancer staging: What the surgeon needs to know","volume":"94","author":"Oliveira","year":"2021","journal-title":"Br J Radiol"}],"container-title":["Current Problems in Diagnostic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363018824001488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0363018824001488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T03:16:54Z","timestamp":1739675814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0363018824001488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0363018824001488"],"URL":"https:\/\/doi.org\/10.1067\/j.cpradiol.2024.08.009","relation":{},"ISSN":["0363-0188"],"issn-type":[{"type":"print","value":"0363-0188"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The tipping point: Key oncologic imaging findings resulting in critical changes in the management of malignant genitourinary and gynecological tumors","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Diagnostic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/j.cpradiol.2024.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}